Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants

Programmed death-ligand 1(PD-L1) expression on tumor cells is emerging as a potential predictive biomarker in anti-PD-L1 directed cancer immunotherapy. We analyzed PD-L1 expression in papillary thyroid carcinoma (PTC) and its variants and determined its prognostic potential to predict clinical outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Subrata, Veyhl, Joe, Jessa, Fatima, Polyakova, Olena, Alenzi, Ahmed, MacMillan, Christina, Ralhan, Ranju, Walfish, Paul G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078015/
https://www.ncbi.nlm.nih.gov/pubmed/27086918
http://dx.doi.org/10.18632/oncotarget.8698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078015/
https://www.ncbi.nlm.nih.gov/pubmed/27086918
http://dx.doi.org/10.18632/oncotarget.8698

Ejemplares similares